Cholesterol and Dementia
Peter expresses concern over the relationship between cholesterol synthesis markers and dementia risk, highlighting the limitations of current cholesterol treatments. Ron elaborates on the pharmacokinetics of statins, emphasizing the importance of targeting the liver while acknowledging the unintended effects on peripheral tissues, including the brain and muscles. Their discussion underscores the complexities of statin therapy and its broader implications for health.In this clip
From this podcast
The Peter Attia Drive Podcast
#03 – Ron Krauss, M.D.: a deep dive into heart disease
Related Questions